The immunology and inflammation (I&I) sector is currently witnessing a surge in strategic acquisitions and innovative drug development, as companies like Novartis and Vertex aim to capitalize on ...

The U.S. API market presents significant growth opportunities driven by rising chronic disease prevalence, expansion of ...

Immunometabolism have advanced the understanding of dynamic interplay between metabolic pathways and immune responses.

Boehringer Ingelheim inks research pact with Trutino to grow cancer immunology portfolio with novel Cytokine platform: Ingelheim, Germany Saturday, February 29, 2020, 10:00 Hrs [I ...

Data support NEK7 as a potential novel and differentiated therapeutic approach to modulate the NLRP3 inflammasome in multiple cardiovascular and cardiometabolic diseases, including pericarditis and at ...